Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST
Stopped Exposure of these high-risk patients to clinic or in-person visits during the pandemic presented an unacceptable risk to their health
Conditions
- Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Interventions
- DRUG: Placebo capsules
- DRUG: Bardoxolone methyl capsules
Sponsor
Biogen